Decheng Capital LLC Diversified Active

CIK: 0002010850 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $466,229 (100.0% shares, 0.0% debt)

Holdings (28)

CGON CG ONCOLOGY INC 39.2%

Value ($000) $182,739 Shares 6,371,669 Est. Cost $39.91 Unrealized -14.3%

NUVB Nuvation Bio Inc. 14.8%

Value ($000) $69,039 Shares 25,954,439 Est. Cost $3.05 Unrealized -15.6%

UPB Upstream Bio Inc. 11.6%

Value ($000) $54,010 Shares 3,285,293 Est. Cost $22.33 Unrealized 0.0%

NAMS NEWAMSTERDAM PHARMA CO NV 4.2%

Value ($000) $19,789 Shares 770,000 Est. Cost $19.66 Unrealized +8.1%

ILMN Illumnia, Inc. 2.7%

Value ($000) $12,664 Shares 94,767 Est. Cost $122.34 Unrealized +16.4%

RCUS Arcus Biosciences, Inc 2.6%

Value ($000) $12,043 Shares 808,789 Est. Cost $15.98 Unrealized +2.2%

KRYS KRYSTAL BIOTECH INC 2.6%

Value ($000) $12,027 Shares 76,772 Est. Cost $121.63 Unrealized +45.9%

RVMD REVOLUTION MEDICINES INC(NSM) 2.1%

Value ($000) $9,885 Shares 226,000 Est. Cost $50.40 Unrealized +0.1%

MLTX MOONLAKE IMMUNOTHERAPEUTICS 2.0%

Value ($000) $9,292 Shares 171,600 Est. Cost $50.34 Unrealized —

CRNX CRINETICS PHARMACEUTICALS IN 1.8%

Value ($000) $8,588 Shares 167,958 Est. Cost $40.13 Unrealized +39.4%

BYSI BeyondSpring Inc. 1.7%

Value ($000) $7,959 Shares 4,882,651 Est. Cost $0.92 Unrealized +114.4%

— MERUS NV 1.7%

Value ($000) $7,952 Shares 189,098 Est. Cost $51.07 Unrealized —

— Lyell Immunopharma, Inc. 1.6%

Value ($000) $7,622 Shares 11,909,341 Est. Cost $0.64 Unrealized —

ZNTL Zentalis Pharmaceuticals Inc. 1.5%

Value ($000) $7,084 Shares 2,338,095 Est. Cost $13.39 Unrealized -75.5%

ACLX ARCELLX INC 1.4%

Value ($000) $6,471 Shares 84,377 Est. Cost $81.25 Unrealized +6.3%

PHAT PHATHOM PHARMACEUTICALS INC 1.2%

Value ($000) $5,637 Shares 694,254 Est. Cost $10.33 Unrealized +19.9%

ACRS Aclaris Therapeutics, Inc. 1.2%

Value ($000) $5,621 Shares 2,266,667 Est. Cost $2.49 Unrealized 0.0%

LEGN LEGEND BIOTECH CORP-ADR 1.1%

Value ($000) $4,997 Shares 153,558 Est. Cost $47.77 Unrealized —

CYTK CYTOKINETICS INC 1.0%

Value ($000) $4,704 Shares 100,000 Est. Cost $75.83 Unrealized -31.5%

BNTX Biontech SE-ADR 1.0%

Value ($000) $4,558 Shares 40,000 Est. Cost $113.95 Unrealized —

AURA Aura Biosciences, Inc. 0.9%

Value ($000) $4,238 Shares 515,555 Est. Cost $8.47 Unrealized +11.1%

EQ Equillium Inc. 0.7%

Value ($000) $3,327 Shares 4,447,308 Est. Cost $0.59 Unrealized +39.0%

FDMT 4D MOLECULAR THERAPEUTICS IN 0.5%

Value ($000) $2,228 Shares 400,000 Est. Cost $24.39 Unrealized -67.8%

VERA VERA THERAPEUTICS INC 0.5%

Value ($000) $2,105 Shares 49,767 Est. Cost $39.67 Unrealized +11.6%

ATRC AtriCure Inc. 0.2%

Value ($000) $819 Shares 26,797 Est. Cost $37.19 Unrealized -13.5%

PYXS Pyxis Oncology, Inc (formerly Apexigen) 0.1%

Value ($000) $510 Shares 326,810 Est. Cost $1.71 Unrealized +68.4%

GRAL GRAIL INC 0.0%

Value ($000) $173 Shares 9,684 Est. Cost $16.22 Unrealized +0.2%

— Nuvation Bio Inc. 0.0%

Value ($000) $149 Shares 646,057 Est. Cost $0.16 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG ONCOLOGY INC	6,371,669	$182,739	39.2%	$39.91	-14.3%	COM	156944100
NUVB	Nuvation Bio Inc.	25,954,439	$69,039	14.8%	$3.05	-15.6%	COM	67080N101
UPB	Upstream Bio Inc.	3,285,293	$54,010	11.6%	$22.33	0.0%	COM	91678A107
NAMS	NEWAMSTERDAM PHARMA CO NV	770,000	$19,789	4.2%	$19.66	+8.1%	COM	N62509109
ILMN	Illumnia, Inc.	94,767	$12,664	2.7%	$122.34	+16.4%	COM	452327109
RCUS	Arcus Biosciences, Inc	808,789	$12,043	2.6%	$15.98	+2.2%	COM	03969F109
KRYS	KRYSTAL BIOTECH INC	76,772	$12,027	2.6%	$121.63	+45.9%	COM	501147102
RVMD	REVOLUTION MEDICINES INC(NSM)	226,000	$9,885	2.1%	$50.40	+0.1%	COM	76155X100
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	171,600	$9,292	2.0%	$50.34	—	COM	G4444C102
CRNX	CRINETICS PHARMACEUTICALS IN	167,958	$8,588	1.8%	$40.13	+39.4%	COM	22663K107
BYSI	BeyondSpring Inc.	4,882,651	$7,959	1.7%	$0.92	+114.4%	SHS	G10830100
—	MERUS NV	189,098	$7,952	1.7%	$51.07	—	COM	N5749R100
—	Lyell Immunopharma, Inc.	11,909,341	$7,622	1.6%	$0.64	—	COM	55083R104
ZNTL	Zentalis Pharmaceuticals Inc.	2,338,095	$7,084	1.5%	$13.39	-75.5%	COM	98943L107
ACLX	ARCELLX INC	84,377	$6,471	1.4%	$81.25	+6.3%	COM	03940C100
PHAT	PHATHOM PHARMACEUTICALS INC	694,254	$5,637	1.2%	$10.33	+19.9%	COM	71722W107
ACRS	Aclaris Therapeutics, Inc.	2,266,667	$5,621	1.2%	$2.49	0.0%	COM	00461U105
LEGN	LEGEND BIOTECH CORP-ADR	153,558	$4,997	1.1%	$47.77	—	ADR	52490G102
CYTK	CYTOKINETICS INC	100,000	$4,704	1.0%	$75.83	-31.5%	COM	23282W605
BNTX	Biontech SE-ADR	40,000	$4,558	1.0%	$113.95	—	COM	09075V102
AURA	Aura Biosciences, Inc.	515,555	$4,238	0.9%	$8.47	+11.1%	COM	05153U107
EQ	Equillium Inc.	4,447,308	$3,327	0.7%	$0.59	+39.0%	COM	29446K106
FDMT	4D MOLECULAR THERAPEUTICS IN	400,000	$2,228	0.5%	$24.39	-67.8%	COM	35104E100
VERA	VERA THERAPEUTICS INC	49,767	$2,105	0.5%	$39.67	+11.6%	COM	92337R101
ATRC	AtriCure Inc.	26,797	$819	0.2%	$37.19	-13.5%	COM	04963C209
PYXS	Pyxis Oncology, Inc (formerly Apexigen)	326,810	$510	0.1%	$1.71	+68.4%	COM	747324101
GRAL	GRAIL INC	9,684	$173	0.0%	$16.22	+0.2%	COM	384747101
—	Nuvation Bio Inc.	646,057	$149	0.0%	$0.16	—	WARRANTS	67080N119